Lipoadenoma of the parathyroid: characteristics of a rare cause of hyperparathyroidism.


Journal

Endocrine journal
ISSN: 1348-4540
Titre abrégé: Endocr J
Pays: Japan
ID NLM: 9313485

Informations de publication

Date de publication:
28 Oct 2022
Historique:
pubmed: 13 6 2022
medline: 2 11 2022
entrez: 12 6 2022
Statut: ppublish

Résumé

Parathyroid Lipoadenoma (PLA) contains abundant mature adipose tissue and is a rare cause of hyperparathyroidism. This study aimed to investigate the clinical features of PLA in nine patients with primary hyperparathyroidism, including two men and seven women, with ages ranging from 45-84 years (median 60 years). PLA accounted for 0.5% of all parathyroid tumors during the study period. One patient presented with anorexia due to hypercalcemia; however, the other eight patients were asymptomatic. The median preoperative serum intact-parathyroid hormone (iPTH) and calcium levels were 143 pg/mL (range, 102-378) and 10.8 mg/dL (range, 10.3-11.3), respectively. PLA was difficult to identify using ultrasonography (US) as it appears as a moderately hyperechoic nodule and is difficult to distinguish from the surrounding adipose tissues. Only 33% of the lesions (three out of nine lesions) were accurately identified. However, they could be distinctly differentiated from the surrounding tissue using computed tomography (CT). All PLAs were also detected using the sesta-methoxyisobutylisonitrile single-photon emission-computed tomography (SPECT). All the patients were treated by a single gland extirpation. The median size and weight of the PLA were 14 mm (range, 10-22) and 567 mg (range, 200-1,533), respectively. In conclusion, the clinical manifestations of PLA are similar to those of ordinal parathyroid adenomas, except for their unique US and CT images. PLA should be considered as a potential etiologic factor in cases of hyperparathyroidism when the lesions are demonstrated as hyperechoic nodules or unidentified by US but detected by CT or SPECT imaging.

Identifiants

pubmed: 35691821
doi: 10.1507/endocrj.EJ22-0118
doi:

Substances chimiques

Parathyroid Hormone 0
Polyesters 0
Technetium Tc 99m Sestamibi 971Z4W1S09

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1227-1232

Auteurs

Naoyoshi Onoda (N)

Department of Surgery, Kuma Hospital, Kobe 650-0011, Japan.

Mitsuyoshi Hirokawa (M)

Department of Diagnostic Pathology, Kuma Hospital, Kobe 650-0011, Japan.

Akihiro Miya (A)

Department of Surgery, Kuma Hospital, Kobe 650-0011, Japan.

Takahiro Sasaki (T)

Department of Surgery, Kuma Hospital, Kobe 650-0011, Japan.

Makoto Fujishima (M)

Department of Surgery, Kuma Hospital, Kobe 650-0011, Japan.

Hiroo Masuoka (H)

Department of Surgery, Kuma Hospital, Kobe 650-0011, Japan.

Takuya Higashiyama (T)

Department of Surgery, Kuma Hospital, Kobe 650-0011, Japan.

Minoru Kihara (M)

Department of Surgery, Kuma Hospital, Kobe 650-0011, Japan.

Akira Miyauchi (A)

Department of Surgery, Kuma Hospital, Kobe 650-0011, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH